Crossmark

Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab

Crossref DOI link: https://doi.org/10.1186/s13075-017-1499-2

Published Online: 2018-01-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huwart, Anaïs http://orcid.org/0000-0001-6302-2651
Garrigues, Florent

Jousse-Joulin, Sandrine

Marhadour, Thierry

Guellec, Dewi

Cornec, Divi

Gouillou, Maelenn

Saraux, Alain

Devauchelle-Pensec, Valérie
Funding

Funding for this research was provided by:

Roche-Cugai
More Information

Article History

Received: 11 May 2017

Accepted: 18 December 2017

First Online: 25 January 2018

Authors’ information

: Not applicable.

: Patient consent obtained. This study was approved by the appropriate ethics committee (CPP Ouest VI).

: Obtained

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.